This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of microprolactinomas

Authoring team

The treatment of choice is a dopamine agonist e.g. bromocriptine, cabergoline. Treatment generally needs to be continued until the menopause. However some patients appear to undergo remission after treatment for a number of years, especially after pregnancy. Endocrinological advice should be sought if a patient wishes to become pregnant whilst undertaking treatment with a dopamine agonist

If a patient is unable to tolerate dopamine agonist treatment then the patient should be considered for selective trans-sphenoidal surgery.

Reference

  1. Peterssen S et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023 Dec;19(12):722-740.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.